EuropeanIssuers

EQS-News: Cantourage Group SE: Cantourage shortlisted for European Small and Mid-Cap Awards 2023

Retrieved on: 
Monday, September 25, 2023
IPO, European Small and Mid-Cap Awards, Civil service commission, Innovation, EuropeanIssuers, Federation, Cannabis, ISIN, European Commission, Cryptocurrency

Cantourage nominated for "Star of Innovation" category; this recognizes companies that put innovation at the core of their strategy

Key Points: 
  • Cantourage nominated for "Star of Innovation" category; this recognizes companies that put innovation at the core of their strategy
    Winners of the competition will be announced on November 14, 2023 in Bilbao, Spain
    Berlin, September 25, 2023 – Cantourage Group SE (hereinafter "Cantourage", ISIN: DE000A3DSV01, www.cantourage.com ), a leading European producer and distributor of medical cannabis, has made it onto the shortlist and thus into the narrowest group of candidates for the 11th European Small and Mid-Cap Awards 2023.
  • The awards were introduced by the European Commission in 2013 and recognize listed European companies in four different categories.
  • Co-organizers are EuropeanIssuers, a European association of listed companies, and the Federation of European Securities Exchanges (FESE).
  • Philip Schetter, CEO of Cantourage, comments "We are delighted to be shortlisted for the European Small and Mid-Cap Awards.

EQS-News: Pyrum Innovations AG nominated for renowned 'Rising Star' award

Retrieved on: 
Thursday, July 20, 2023
European Small and Mid-Cap Awards, Civil service commission, Executive Vice President of the European Commission for A Europe Fit for the Digital Age, EuropeanIssuers, Dillingen (Saar) station, Recycling, Federation, Elizabeth Elting, European, ISIN, European Commission, Film industry, Zonaria pyrum

Dillingen / Saar, 20 July 2023 - Pyrum Innovations AG ("Pyrum", the "Company", ISIN: DE000A2G8ZX8), a pioneer in the sustainable recycling of end-of-life tyres (ELTs) based on its patented pyrolysis technology, has been nominated for the “Rising Star” award.

Key Points: 
  • Dillingen / Saar, 20 July 2023 - Pyrum Innovations AG ("Pyrum", the "Company", ISIN: DE000A2G8ZX8), a pioneer in the sustainable recycling of end-of-life tyres (ELTs) based on its patented pyrolysis technology, has been nominated for the “Rising Star” award.
  • This year, Pyrum is the only German company among the nominees in this category.
  • Pascal Klein, CEO of Pyrum Innovations AG: "Being nominated as a 'Rising Star' by FESE is an extraordinary honour for us.
  • In addition to Pyrum, eight other European companies are in the running for the prestigious “Rising Star” award.

Nanoform wins Star of Innovation award at the European Small and Mid-Cap Awards 2021

Retrieved on: 
Wednesday, November 17, 2021
GMP, Federation, EuropeanIssuers, European Commission, Heart, COVID, Growth, Star, BioNTech, Patient, IPO, European Small and Mid-Cap Awards, Innovation, Royal commission, AstraZeneca, Pharmaceutical industry

HELSINKI, Nov. 17, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has won the Star of Innovation award at the 9th annual European Small and Mid-Cap Awards.

Key Points: 
  • HELSINKI, Nov. 17, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has won the Star of Innovation award at the 9th annual European Small and Mid-Cap Awards.
  • On the same night, 16thNovember 2021, Nanoform were also shortlisted for two further awards at the European Mediscience Awards which took place in London.
  • The European Small and Mid-Cap Awards, launched in 2013, were established by the European Commission to recognize selected European listed growth companies.
  • Prof. Edward Hggstrm, Nanoform CEO, commented:"We are honored to have received the Star of Innovationaward within European Small and Mid-Cap Awards 2021.

Nanoform wins Star of Innovation award at the European Small and Mid-Cap Awards 2021

Retrieved on: 
Wednesday, November 17, 2021
GMP, Federation, EuropeanIssuers, European Commission, Heart, COVID, Growth, Star, BioNTech, Patient, IPO, European Small and Mid-Cap Awards, Innovation, Royal commission, AstraZeneca, Pharmaceutical industry

HELSINKI, Nov. 17, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has won the Star of Innovation award at the 9th annual European Small and Mid-Cap Awards.

Key Points: 
  • HELSINKI, Nov. 17, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has won the Star of Innovation award at the 9th annual European Small and Mid-Cap Awards.
  • On the same night, 16thNovember 2021, Nanoform were also shortlisted for two further awards at the European Mediscience Awards which took place in London.
  • The European Small and Mid-Cap Awards, launched in 2013, were established by the European Commission to recognize selected European listed growth companies.
  • Prof. Edward Hggstrm, Nanoform CEO, commented:"We are honored to have received the Star of Innovationaward within European Small and Mid-Cap Awards 2021.

Nanoform Shortlisted For The European Small and Mid-Cap Awards 2021

Retrieved on: 
Thursday, September 23, 2021
China-EU Institute for Clean and Renewable Energy, GMP, European Single Market, Goal, Entrepreneurship, Public, EuropeanIssuers, European Small and Mid-Cap Awards, Patient, SME, Royal commission, Growth, DG, Strategic autonomy, Affiliation, IPO, European Commission, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, Innovation, Award, European Commission Investment Plan for Europe, Federation, Security (finance), Renewable energy

HELSINKI, Sept. 23, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has made the shortlist in the `Star of Innovation' category of the 9th annual European Small and Mid-Cap Awards.

Key Points: 
  • HELSINKI, Sept. 23, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has made the shortlist in the `Star of Innovation' category of the 9th annual European Small and Mid-Cap Awards.
  • Nanoform, listed on Nasdaq, was shortlisted from some 27 nominations from 17 countries, listed on different European stock exchanges.
  • They will be revealed at a special Awards ceremony on 16th November during the European Commission's SME Assembly in Portoro, Slovenia.
  • The European Small and Mid-Cap Awards advocate the benefits of equity financing and encourage smaller companies to consider this financing option.

Nanoform Shortlisted For The European Small and Mid-Cap Awards 2021

Retrieved on: 
Thursday, September 23, 2021
China-EU Institute for Clean and Renewable Energy, GMP, European Single Market, Goal, Entrepreneurship, Public, EuropeanIssuers, European Small and Mid-Cap Awards, Patient, SME, Royal commission, Growth, DG, Strategic autonomy, Affiliation, IPO, European Commission, Directorate-General for Internal Market, Industry, Entrepreneurship and SMEs, Innovation, Award, European Commission Investment Plan for Europe, Federation, Security (finance), Renewable energy

HELSINKI, Sept. 23, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has made the shortlist in the `Star of Innovation' category of the 9th annual European Small and Mid-Cap Awards.

Key Points: 
  • HELSINKI, Sept. 23, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has made the shortlist in the `Star of Innovation' category of the 9th annual European Small and Mid-Cap Awards.
  • Nanoform, listed on Nasdaq, was shortlisted from some 27 nominations from 17 countries, listed on different European stock exchanges.
  • They will be revealed at a special Awards ceremony on 16th November during the European Commission's SME Assembly in Portoro, Slovenia.
  • The European Small and Mid-Cap Awards advocate the benefits of equity financing and encourage smaller companies to consider this financing option.